![]() The regional analysis of global Cell Surface Markers Detection market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. However, high cost and time-intensive antibody development process, and complexity in the use of flow cytometry are the few factors expected to hamper the growth of the market over the forecast period of 2020-2026. This, in turn, is expected to accelerate the adoption of product & services relates to cell surface markers detection, thus contributing to the growth of the global market. ![]() Also, the global burden of cancer is expected to grow to almost 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. Request To Download Sample of This Strategic Report:- Īccording to the International Agency for Research on Cancer (IARC), in 2018, there were around 17.0 million new cancer cases and 9.5 million cancer deaths registered throughout the world. ![]() Thus, rise in prevalence of cancer, increasing funding for life science and stem cell research and the advancements in monoclonal antibody production and generation of cell-specific antibodies are the few factors responsible for high CAGR of the market over the forecast period. Further, it can be beneficial in personalized medicine, in which it helps the physician to decide the most efficient therapy to be used for analyzing and understanding the cells isolated from patients. It also assists in the determination of cell type expression of particular receptors, essential for biological response. ![]()
0 Comments
Leave a Reply. |